1 Min Read
May 15 (Reuters) - PHOTOCURE ASA
* POSITIVE DATA FROM PHASE 3 US BLUE LIGHT CYSTOSCOPY WITH CYSVIEW® STUDY
* PLANS TO FILE A SUPPLEMENTAL NDA WITH FDA LATER THIS YEAR Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.